Bhambhvani Hriday P, Chen Tony, Kasman Alex M, Wilson-King Genester, Enemchukwu Ekene, Eisenberg Michael L
Department of Urology, Stanford University Medical Center, Stanford, CA, USA.
Department of Urology, Stanford University Medical Center, Stanford, CA, USA.
Sex Med. 2021 Aug;9(4):100355. doi: 10.1016/j.esxm.2021.100355. Epub 2021 Apr 17.
International studies have demonstrated increasing rates of sexual dysfunction amidst the coronavirus disease 2019 (COVID-19) pandemic; however, the impact of the pandemic on female sexual function in the United States is unknown.
To assess the impact of the COVID-19 pandemic on female sexual function and frequency in the United States.
A pre-pandemic survey containing the Female Sexual Function Index (FSFI) and demographic questions was completed by adult women in the United States from October 20, 2019 and March 1, 2020. The same women were sent a follow-up survey also containing the FSFI, as well as the Patient Health Questionnaire for Depression and Anxiety with 4 items (PHQ-4), and questions pertaining to mask wearing habits, job loss, and relationship changes. Risk for female sexual dysfunction (RFSD) was defined as FSFI < 26.55.
Differences in pre-pandemic and intra-pandemic female sexual function, measured by the FSFI, and sexual frequency.
Ninety-one women were included in this study. Overall FSFI significantly decreased during the pandemic (27.2 vs 28.8, P = .002), with domain-specific decreases in arousal (4.41 vs 4.86, P = .0002), lubrication (4.90 vs 5.22, P = .004), and satisfaction (4.40 vs 4.70, P = .04). There was no change in sexual frequency. Contingency table analysis of RFSD prior to and during the pandemic revealed significantly increased RFSD during the pandemic (P = .002). Women who developed RFSD during the pandemic had higher PHQ-4 anxiety subscale scores (3.74 vs 2.53, P = .01) and depression subscale scores (2.74 vs 1.43, P = .001) than those who did not. Development of FSD was not associated with age, home region, relationship status, mask wearing habits, knowing someone who tested positive for COVID-19, relationship change, or job loss and/or reduction during the pandemic.
In this population of female cannabis users, risk for sexual dysfunction increased amidst the COVID-19 pandemic and is associated with depression and anxiety symptoms. Bhambhvani HP, Chen T, Wilson-King AM, et al. Female Sexual Function During the COVID-19 Pandemic in the United States. Sex Med 2021;9:100355.
国际研究表明，在2019年冠状病毒病（COVID-19）大流行期间，性功能障碍的发生率不断上升；然而，大流行对美国女性性功能的影响尚不清楚。
评估COVID-19大流行对美国女性性功能及频率的影响。
2019年10月20日至2020年3月1日期间，美国成年女性完成了一项大流行前的调查，其中包含女性性功能指数（FSFI）和人口统计学问题。同样这些女性收到了一份后续调查，其中也包含FSFI，以及4项条目版的抑郁焦虑患者健康问卷（PHQ-4），还有与佩戴口罩习惯、失业和关系变化相关的问题。女性性功能障碍风险（RFSD）定义为FSFI<26.55。
通过FSFI测量的大流行前和大流行期间女性性功能的差异以及性行为频率。
本研究纳入了91名女性。在大流行期间，总体FSFI显著下降（27.2对28.8，P = .002），在性唤起（4.41对4.86，P = .0002）、润滑（4.90对5.22，P = .004）和满意度（4.40对4.70，P = .04）等特定领域有所下降。性行为频率没有变化。对大流行前和大流行期间RFSD的列联表分析显示，大流行期间RFSD显著增加（P = .002）。在大流行期间出现RFSD的女性，其PHQ-4焦虑分量表得分（3.74对2.53，P = .01）和抑郁分量表得分（2.74对1.43，P = .001）高于未出现RFSD的女性。性功能障碍的发生与年龄、家乡地区、恋爱状况、佩戴口罩习惯、认识COVID-19检测呈阳性的人、关系变化或大流行期间失业和/或收入减少无关。
在这群女性大麻使用者中，COVID-19大流行期间性功能障碍风险增加，且与抑郁和焦虑症状相关。班布瓦尼HP、陈T、威尔逊-金AM等。美国COVID-19大流行期间的女性性功能。性医学2021；9：100355。
